Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
Brentuximab vedotin联合AVD治疗II-IV期HIV相关霍奇金淋巴瘤(AMC 085):一项开放标签、单臂、多中心1/2期试验的2期结果
期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(23)00157-6
Rubinstein, Paul G; Moore, Page C; Bimali, Milan; Lee, Jeanette Y; Rudek, Michelle A; Chadburn, Amy; Ratner, Lee; Henry, David H; Cesarman, Ethel; DeMarco, Camille E; Costagliola, Dominique; Taoufik, Yassine; Ramos, Juan Carlos; Sharon, Elad; Reid, Erin G; Ambinder, Richard F; Mitsuyasu, Ronald; Mounier, Nicolas; Besson, Caroline; Noy, Ariela